Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

NCT04875702 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Gout

Interventions

DRUG: Allopurinol
DRUG: Naproxen 250 MG
DRUG: Colchicine 0.6 mg
DRUG: Colchicine 1.2 mg
DRUG: Naproxen 500 Mg
DRUG: Prednisone 40 mg

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]